Related references
Note: Only part of the references are listed.Mucosal fungi promote gut barrier function and social behavior via Type 17 immunity
Irina Leonardi et al.
CELL (2022)
Saroglitazar, a PPAR-α/γ Agonist, for Treatment of Nonalcoholic Fatty Liver Disease: A Randomized Controlled Double-Blind Phase 2 Trial
Manas Kumar Panigrahi et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2022)
Astaxanthin Attenuates Adiponectin, Calprotectin, miRNA222 and miRNA378 in Obesity induced by High-Fat Diet in Rats
Sylvia A. Boshra
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2022)
Effects of caloric restriction on the gut microbiome are linked with immune senescence
Julia Sbierski-Kind et al.
MICROBIOME (2022)
Lean non-alcoholic fatty liver disease (Lean-NAFLD) and the development of metabolic syndrome: a retrospective study
Wenting Wang et al.
SCIENTIFIC REPORTS (2022)
Can we reduce autism-related gastrointestinal and behavior problems by gut microbiota based dietary modulation? A review
Nalan Hakime Nogay et al.
NUTRITIONAL NEUROSCIENCE (2021)
Gut microorganisms and neurological disease perspectives
Nairita Ahsan Faruqui et al.
FUTURE NEUROLOGY (2021)
Sweet death: Fructose as a metabolic toxin that targets the gut-liver axis
Mark A. Febbraio et al.
CELL METABOLISM (2021)
Molecular aspects of fructose metabolism and metabolic disease
Mark A. Herman et al.
CELL METABOLISM (2021)
Emerging therapies for the treatment of nonalcoholic steatohepatitis: A systematic review
Erenie Guirguis et al.
PHARMACOTHERAPY (2021)
Regulation of Gastrointestinal Immunity by Metabolites
Bon-Hee Gu et al.
NUTRIENTS (2021)
Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?
Young Jin Tak et al.
CURRENT OBESITY REPORTS (2021)
The gut mycobiome of healthy mice is shaped by the environment and correlates with metabolic outcomes in response to diet
Tahliyah S. Mims et al.
COMMUNICATIONS BIOLOGY (2021)
The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine
Deyang Yu et al.
CELL METABOLISM (2021)
Fructose and metabolic diseases: too much to be good
Ya-Nan Shi et al.
CHINESE MEDICAL JOURNAL (2021)
The intestinal mycobiome as a determinant of host immune and metabolic health
Mackenzie W. Gutierrez et al.
CURRENT OPINION IN MICROBIOLOGY (2021)
Synergistic effects of fructose and glucose on lipoprotein risk factors for cardiovascular disease in young adults (vol 112, 154356, 2020)
Bettina Hieronimus et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
Dietary fructose improves intestinal cell survival and nutrient absorption
Samuel R. Taylor et al.
NATURE (2021)
Enterically derived high-density lipoprotein restrains liver injury through the portal vein
Yong-Hyun Han et al.
SCIENCE (2021)
Visceral obesity and insulin resistance associate with CD36 deletion in lymphatic endothelial cells
Vincenza Cifarelli et al.
NATURE COMMUNICATIONS (2021)
Effect of Diet and Dietary Components on the Composition of the Gut Microbiota
Ashley Beam et al.
NUTRIENTS (2021)
Saroglitazar, a PPAR-α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial
Samer Gawrieh et al.
HEPATOLOGY (2021)
Inhibition of ketohexokinase in adults with NAFLD reduces liver fat and inflammatory markers: A randomized phase 2 trial
David J. Kazierad et al.
MED (2021)
Gut dysbiosis as a driver in alcohol-induced liver injury
Bradley Fairfield et al.
JHEP REPORTS (2021)
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Agustin Albillos et al.
JOURNAL OF HEPATOLOGY (2020)
Regulation of intestinal lipid metabolism: current concepts and relevance to disease
Chih-Wei Ko et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature
Mauro Giuffre et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2020)
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
Tao Zuo et al.
GASTROENTEROLOGY (2020)
Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease
Angeliki Katsarou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate
Steven Zhao et al.
NATURE (2020)
The gut-brain axis mediates sugar preference
Hwei-Ee Tan et al.
NATURE (2020)
Sugar causes obesity and metabolic syndrome in mice independently of sweet taste
Ana Andres-Hernando et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2020)
Assessment of energy expenditure: are calories measured differently for different diets?
Guillermo Sanchez-Delgado et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2020)
High-Fat Diet and Antibiotics Cooperatively Impair Mitochondrial Bioenergetics to Trigger Dysbiosis that Exacerbates Pre-inflammatory Bowel Disease
Jee-Yon Lee et al.
CELL HOST & MICROBE (2020)
Deletion of Fructokinase in the Liver or in the Intestine Reveals Differential Effects on Sugar-Induced Metabolic Dysfunction
Ana Andres-Hernando et al.
CELL METABOLISM (2020)
Current and Future Treatments in the Fight against Non-Alcoholic Fatty Liver Disease
Benoit Smeuninx et al.
CANCERS (2020)
The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation
Chiara Amoroso et al.
CELLS (2020)
Very-Low-Calorie Ketogenic Diets With Whey, Vegetable, or Animal Protein in Patients With Obesity: A Randomized Pilot Study
Sabrina Basciani et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Pattern Recognition Receptors: Significance of Expression in the Liver
Jan Zeromski et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2020)
Can You Trust Your Gut? Implicating a Disrupted Intestinal Microbiome in the Progression of NAFLD/NASH
Kavita Jadhav et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Comprehensive Review of Current and Upcoming Anti-Obesity Drugs
Jang Won Son et al.
DIABETES & METABOLISM JOURNAL (2020)
Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction
Jemy A. Gutierrez et al.
MOLECULAR METABOLISM (2020)
Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis
Julia J. Witjes et al.
HEPATOLOGY COMMUNICATIONS (2020)
The small intestine shields the liver from fructose-induced steatosis
Cholsoon Jang et al.
NATURE METABOLISM (2020)
Fructose stimulated de novo lipogenesis is promoted by inflammation
Jelena Todoric et al.
NATURE METABOLISM (2020)
Dietary fat and gut microbiota: mechanisms involved in obesity control
Olivia Goncalves Leao Coelho et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2019)
A review of probiotic supplementation in healthy adults: helpful or hype?
Saman Khalesi et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2019)
Intestinal non-canonical NFκB signaling shapes the local and systemic immune response
Sadeesh K. Ramakrishnan et al.
NATURE COMMUNICATIONS (2019)
A Novel Postbiotic From Lactobacillus rhamnosus GG With a Beneficial Effect on Intestinal Barrier Function
Jie Gao et al.
FRONTIERS IN MICROBIOLOGY (2019)
Treatment of type 2 diabetes with the designer cytokine IC7Fc
Maria Findeisen et al.
NATURE (2019)
Gut microbiota in phytopharmacology: A comprehensive overview of concepts, reciprocal interactions, biotransformations and mode of actions
Priyankar Dey
PHARMACOLOGICAL RESEARCH (2019)
Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?
Mark A. Febbraio et al.
CELL METABOLISM (2019)
Non-alcoholic fatty liver disease in lean individuals
Somaya Albhaisi et al.
JHEP REPORTS (2019)
The gut virome: the 'missing link' between gut bacteria and host immunity?
Indrani Mukhopadhy et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)
Amino Acid Transport Across the Mammalian Intestine
Stefan Broer et al.
COMPREHENSIVE PHYSIOLOGY (2019)
Current and future pharmacological therapies for NAFLD/NASH
Yoshio Sumida et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Intestinal Absorption of Fructose
Ronaldo P. Ferraris et al.
ANNUAL REVIEW OF NUTRITION, VOL 38 (2018)
short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders
P. A. Gill et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids
Cholsoon Jang et al.
CELL METABOLISM (2018)
Food Design To Feed the Human Gut Microbiota
Danilo Ercolini et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2018)
Lipotoxicity and the gut-liver axis in NASH pathogenesis
Fabio Marra et al.
JOURNAL OF HEPATOLOGY (2018)
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Thomas Jensen et al.
JOURNAL OF HEPATOLOGY (2018)
ChREBP deficiency leads to diarrhea-predominant irritable bowel syndrome
Ah-Reum Oh et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Goblet cells: multifaceted players in immunity at mucosal surfaces
Kathryn A. Knoop et al.
MUCOSAL IMMUNOLOGY (2018)
The gut-liver axis and the intersection with the microbiome
Anupriya Tripathi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
The Intestinal Epithelium: Central Coordinator of Mucosal Immunity
Joannie M. Allaire et al.
TRENDS IN IMMUNOLOGY (2018)
The Western Diet-Microbiome-Host Interaction and Its Role in Metabolic Disease
Marit K. Zinocker et al.
NUTRIENTS (2018)
ChREBP-Knockout Mice Show Sucrose Intolerance and Fructose Malabsorption
Takehiro Kato et al.
NUTRIENTS (2018)
Lacteal junction zippering protects against diet-induced obesity
Feng Zhang et al.
SCIENCE (2018)
Early-Life Sugar Consumption Affects the Rat Microbiome Independently of Obesity
Emily E. Noble et al.
JOURNAL OF NUTRITION (2017)
Diet as a Trigger or Therapy for Inflammatory Bowel Diseases
James D. Lewis et al.
GASTROENTEROLOGY (2017)
The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS
Heidi M. Staudacher et al.
GUT (2017)
The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases
Min-Hyun Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Deleterious Metabolic Effects of High Fructose Intake: The Preventive Effect of Lactobacillus kefiri Administration
Maria Guillermina Zubiria et al.
NUTRIENTS (2017)
Current and future treatment options in non-alcoholic steatohepatitis (NASH)
Nikos Lazaridis et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2017)
Dietary fructose causes defective insulin signalling and ceramide accumulation in the liver that can be reversed by gut microbiota modulation
Raffaella Crescenzo et al.
FOOD & NUTRITION RESEARCH (2017)
New developments in the treatment of primary biliary cholangitis - role of obeticholic acid
Manan A. Jhaveri et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2017)
Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota
Da Zhou et al.
SCIENTIFIC REPORTS (2017)
Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation (vol 26, pg 394, 2017)
Chai-Wan Kim et al.
CELL METABOLISM (2017)
Predictors of response to a low-FODMAP diet in patients with functional gastrointestinal disorders and lactose or fructose intolerance
C. H. Wilder-Smith et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Review article: insights into colonic protein fermentation, its modulation and potential health implications
C. K. Yao et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
High-intensity exercise training increases the diversity and metabolic capacity of the mouse distal gut microbiota during diet-induced obesity
Emmanuel Denou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Control of chylomicron export from the intestine
Charles M. Mansbach et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Physiology of Intestinal Absorption and Secretion
Pawel R. Kiela et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2016)
Recent discoveries on absorption of dietary fat: Presence, synthesis, and metabolism of cytoplasmic lipid droplets within enterocytes
Theresa D'Aquila et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)
A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility
Mahesh S. Desai et al.
CELL (2016)
Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice
Camella G. Wilson et al.
ENDOCRINOLOGY (2016)
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu et al.
GASTROENTEROLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease
Talat Bessissow et al.
INFLAMMATORY BOWEL DISEASES (2016)
Thematic Review Series: Lipotoxicity: Many Roads to Cell Dysfunction and Cell Death Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis
Petra Hirsova et al.
JOURNAL OF LIPID RESEARCH (2016)
High Fat Diets Induce Colonic Epithelial Cell Stress and Inflammation that is Reversed by IL-22
Max Gulhane et al.
SCIENTIFIC REPORTS (2016)
Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome
Siegfried Ussar et al.
MOLECULAR METABOLISM (2016)
Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases
James L. Richards et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
Fructose-induced increases in expression of intestinal fructolytic and gluconeogenic genes are regulated by GLUT5 and KHK
Chirag Patel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2015)
Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling
Robert Caesar et al.
CELL METABOLISM (2015)
Blocking IL-6 trans-Signaling Prevents High-Fat Diet-Induced Adipose Tissue Macrophage Recruitment but Does Not Improve Insulin Resistance
Michael J. Kraakman et al.
CELL METABOLISM (2015)
Role of endoplasmic reticulum stress and autophagy as interlinking pathways in the pathogenesis of inflammatory bowel disease
Shuhei Hosomi et al.
CURRENT OPINION IN GASTROENTEROLOGY (2015)
Metabolites of Dietary Protein and Peptides by Intestinal Microbes and their Impacts on Gut
Peixin Fan et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2015)
ORAL THERAPY WITH NON-ABSORBABLE CARBONS OF CONTROLLED POROSITY (YAQ-001) SELECTIVELY MODULATES STOOL MICROBIOME AND ITS FUNCTION AND THIS IS ASSOCIATED WITH RESTORATION OF IMMUNE FUNCTION AND INFLAMMASOME ACTIVATION
J. Macnaughtan et al.
JOURNAL OF HEPATOLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease
Weiwei Jiang et al.
SCIENTIFIC REPORTS (2015)
Obesity changes the human gut mycobiome
M. Mar Rodriguez et al.
SCIENTIFIC REPORTS (2015)
Commensal Gram-positive bacteria initiates colitis by inducing monocyte/macrophage mobilization
Y. Nakanishi et al.
MUCOSAL IMMUNOLOGY (2015)
Changes in Gut Microbiota in Rats Fed a High Fat Diet Correlate with Obesity-Associated Metabolic Parameters
Virginie Lecomte et al.
PLOS ONE (2015)
Microbial Enterotypes, Inferred by the Prevotella-to-Bacteroides Ratio, Remained Stable during a 6-Month Randomized Controlled Diet Intervention with the New Nordic Diet
Henrik M. Roager et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2014)
Intestinal microbiota, diet and health
Susan E. Power et al.
BRITISH JOURNAL OF NUTRITION (2014)
CerS2 Haploinsufficiency Inhibits β-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance (vol, 20, pg 687, 2014)
Suryaprakash Raichur et al.
CELL METABOLISM (2014)
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society
Michael D. Jensen et al.
CIRCULATION (2014)
Intestinal lipid absorption and lipoprotein formation
M. Mahmood Hussain
CURRENT OPINION IN LIPIDOLOGY (2014)
Ceramides and Glucosylceramides Are Independent Antagonists of Insulin Signaling
Jose A. Chavez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent
Lay T. Gan et al.
JOURNAL OF HEPATOLOGY (2014)
Diet rapidly and reproducibly alters the human gut microbiome
Lawrence A. David et al.
NATURE (2014)
Artificial sweeteners induce glucose intolerance by altering the gut microbiota
Jotham Suez et al.
NATURE (2014)
Myosin Light Chain Kinase Expression Induced via Tumor Necrosis Factor Receptor 2 Signaling in the Epithelial Cells Regulates the Development of Colitis-Associated Carcinogenesis
Masahiro Suzuki et al.
PLOS ONE (2014)
Butyrate Protects Rat Liver against Total Hepatic Ischemia Reperfusion Injury with Bowel Congestion
Bin Liu et al.
PLOS ONE (2014)
The impact of date palm fruits and their component polyphenols, on gut microbial ecology, bacterial metabolites and colon cancer cell proliferation
Noura Eid et al.
JOURNAL OF NUTRITIONAL SCIENCE (2014)
Dietary fructose induces endotoxemia and hepatic injury in calorically controlled primates
Kylie Kavanagh et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2013)
Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids
Gijs den Besten et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent
Laura Wrzosek et al.
BMC BIOLOGY (2013)
Hepatoprotective Effects of the Dual Peroxisome Proliferator-Activated Receptor Alpha/Delta Agonist, GFT505, in Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Bart Staels et al.
HEPATOLOGY (2013)
Lack of evidence for high fructose corn syrup as the cause of the obesity epidemic
D. M. Klurfeld et al.
INTERNATIONAL JOURNAL OF OBESITY (2013)
The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome 'at-risk' population
F. Fava et al.
INTERNATIONAL JOURNAL OF OBESITY (2013)
Role of diet and nutritional management in non-alcoholic fatty liver disease
Jian-Gao Fan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis
George N. Ioannou et al.
JOURNAL OF LIPID RESEARCH (2013)
Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium
N. A. Mabbott et al.
MUCOSAL IMMUNOLOGY (2013)
Hepatic Crown-Like Structure: A Unique Histological Feature in Non-Alcoholic Steatohepatitis in Mice and Humans
Michiko Itoh et al.
PLOS ONE (2013)
Presence of Apolipoprotein C-III Defines a High Density Lipoprotein Subtype that is not Inversely Associated with Incident Coronary Events
Majken K. Jensen et al.
CIRCULATION (2013)
Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study
Maria Maersk et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dianne H. Dapito et al.
CANCER CELL (2012)
Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease
Hae-Ki Min et al.
CELL METABOLISM (2012)
A High-Fat Diet Is Associated With Endotoxemia That Originates From the Gut
Swaroop Pendyala et al.
GASTROENTEROLOGY (2012)
Women With and Without Metabolic Disorder Differ in Their Gut Microbiota Composition
Eveliina Munukka et al.
OBESITY (2012)
Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection
Saranna Fanning et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Role of ceramides in nonalcoholic fatty liver disease
Mangesh Pagadala et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Pregnane X receptor as a target for treatment of inflammatory bowel disorders
Jie Cheng et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Diet-Induced Dysbiosis of the Intestinal Microbiota and the Effects on Immunity and Disease
Kirsty Brown et al.
NUTRIENTS (2012)
Epithelial antimicrobial defence of the skin and intestine
Richard L. Gallo et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans
Reiner Jumpertz et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
Bovine colostrum as a biologic in clinical medicine: A review – Part II: Clinical studies
W.G. Struff et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
The study on the impact of glycated pea proteins on human intestinal bacteria
Swiatecka Dominika et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2011)
A role for mitochondria in NLRP3 inflammasome activation
Rongbin Zhou et al.
NATURE (2011)
Diet, gut microbiota and immune responses
Kendle M. Maslowski et al.
NATURE IMMUNOLOGY (2011)
Predicting a Human Gut Microbiota's Response to Diet in Gnotobiotic Mice
Jeremiah J. Faith et al.
SCIENCE (2011)
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
Gary D. Wu et al.
SCIENCE (2011)
Human intestinal microbiota and healthy ageing
Kirsti Tiihonen et al.
AGEING RESEARCH REVIEWS (2010)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
Interleukin-6 Signaling in Liver-Parenchymal Cells Suppresses Hepatic Inflammation and Improves Systemic Insulin Action
F. Thomas Wunderlich et al.
CELL METABOLISM (2010)
Is Interleukin-6 Receptor Blockade the Holy Grail for Inflammatory Diseases?
M. A. Febbraio et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Human IL6 enhances leptin action in mice
M. Sadagurski et al.
DIABETOLOGIA (2010)
Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance
V. B. Matthews et al.
DIABETOLOGIA (2010)
Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis
Kittichai Promrat et al.
HEPATOLOGY (2010)
Increased Fructose Consumption Is Associated with Fibrosis Severity in Patients with Nonalcoholic Fatty Liver Disease
Manal F. Abdelmalek et al.
HEPATOLOGY (2010)
The Sensing of Environmental Stimuli by Follicular Dendritic Cells Promotes Immunoglobulin A Generation in the Gut
Keiichiro Suzuki et al.
IMMUNITY (2010)
Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis
Yuko Akazawa et al.
JOURNAL OF HEPATOLOGY (2010)
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa
Carlotta De Filippo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
High-density lipoprotein and the acute phase response
Anisa Jahangiri
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2010)
Current Views of Toll-Like Receptor Signaling Pathways
Masahiro Yamamoto et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2010)
Immune responses to gut microbiota-commensals and pathogens
Takeshi Tanoue et al.
GUT MICROBES (2010)
The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age
D. Mariat et al.
BMC MICROBIOLOGY (2009)
High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus
Brian G. Drew et al.
CIRCULATION (2009)
The Anti Inflammatory Effects of High Density Lipoproteins
A. J. Murphy et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Slc2a5 (Glut5) Is Essential for the Absorption of Fructose in the Intestine and Generation of Fructose-induced Hypertension
Sharon Barone et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
Kimber L. Stanhope et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Ketohexokinase: Expression and Localization of the Principal Fructose-metabolizing Enzyme
Christine P. Diggle et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2009)
National Estimates of Dietary Fructose Intake Increased from 1977 to 2004 in the United States
Bernadette P. Marriott et al.
JOURNAL OF NUTRITION (2009)
A Brief Report of the Epidemiology of Obesity in the Inflammatory Bowel Disease Population of Tayside, Scotland
Helen Steed et al.
OBESITY FACTS (2009)
Intestinal mucosal barrier function in health and disease
Jerrold R. Turner
NATURE REVIEWS IMMUNOLOGY (2009)
Voluntary ethanol consumption in 22 inbred mouse strains
Naomi Yoneyama et al.
ALCOHOL (2008)
Regulation of the fructose transporter GLUT5 in health and disease
Veronique Douard et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome
Peter J. Turnbaugh et al.
CELL HOST & MICROBE (2008)
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Patrice D. Cani et al.
DIABETES (2008)
Toll-like receptors and adaptor molecules in liver disease: Update
Ekihiro Seki et al.
HEPATOLOGY (2008)
Energy metabolism, fuel selection and body weight regulation
J. Galgani et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Xiaosen Ouyang et al.
JOURNAL OF HEPATOLOGY (2008)
Nuclear receptors of the enteric tract: guarding the frontier
Daniel R. Schmidt et al.
NUTRITION REVIEWS (2008)
Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver
Scott L. Friedman
PHYSIOLOGICAL REVIEWS (2008)
TLR4 enhances TGF-β signaling and hepatic fibrosis
Ekihiro Seki et al.
NATURE MEDICINE (2007)
The inflammasome in pathogen recognition and inflammation
Fayyaz S. Sutterwala et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Facilitated hexose transporters: New perspectives on form and function
Andrei R. Manolescu et al.
PHYSIOLOGY (2007)
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
Willscott E. Naugler et al.
SCIENCE (2007)
Metabolic endotoxemia initiates obesity and insulin resistance
Patrice D. Cani et al.
DIABETES (2007)
Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function
E. Cario et al.
GASTROENTEROLOGY (2007)
Selective colonization of insoluble substrates by human faecal bacteria
E. Carol McWilliam Leitch et al.
ENVIRONMENTAL MICROBIOLOGY (2007)
PPARα mediates the hypolipidemic action of fibrates by antagonizing FoxO1
Shen Qu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Effects of high-fructose corn syrup and sucrose consumption on circulating glucose, insulin, leptin, and ghrelin and on appetite in normal-weight women
Kathleen J. Melanson et al.
NUTRITION (2007)
An obesity-associated gut microbiome with increased capacity for energy harvest
Peter J. Turnbaugh et al.
NATURE (2006)
Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase
Andrew L. Carey et al.
DIABETES (2006)
Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis
Montserrat Mari et al.
CELL METABOLISM (2006)
The gut flora as a forgotten organ
Ann M. O'Hara et al.
EMBO REPORTS (2006)
Endothelial and antithrombotic actions of HDL
Chieko Mineo et al.
CIRCULATION RESEARCH (2006)
LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice
Fuyumi Isayama et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease
Shira Zelber-Sagi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Obesity in Canada: where and how many?
A Vanasse et al.
INTERNATIONAL JOURNAL OF OBESITY (2006)
A review of issues of dietary protein intake in humans
S Bilsborough et al.
INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM (2006)
Characteristics of intestinal dendritic cells in inflammatory bowel diseases
AL Hart et al.
GASTROENTEROLOGY (2005)
Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease
JM Clark et al.
OBESITY RESEARCH (2005)
NALP3 forms an IL-lβ-Processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder
L Agostini et al.
IMMUNITY (2004)
IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer
FR Greten et al.
CELL (2004)
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis
S Rakoff-Nahoum et al.
CELL (2004)
Interferon regulatory factor 1 (IRF-1) and IRF-2 distinctively up-regulate gene expression and production of interleukin-7 in human intestinal epithelial cells
S Oshima et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction
MA Febbraio et al.
DIABETES (2004)
XENical in the prevention of diabetes in obese subjects (XENDOS) study
JS Torgerson et al.
DIABETES CARE (2004)
Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women
KL Teff et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Molecular and integrative physiology of intestinal peptide transport
H Daniel
ANNUAL REVIEW OF PHYSIOLOGY (2004)
Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism
K Hanada
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2003)
Accelerated fat absorption in intestinal alkaline phosphatase knockout mice
S Narisawa et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Butyrate inhibits NF-κB activation in lamina propria macrophages of patients with ulcerative colitis
H Lührs et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2002)
Localization of the lipid receptors CD36 and CLA-1/SR-BI in the human gastrointestinal tract:: Towards the identification of receptors mediating the intestinal absorption of dietary lipids
MVT Lobo et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2001)
Share Paper
